Translational Research Program 2025-2026

The Translational Research Program (TRP) was formed to enhance the transfer of basic research findings to clinical usefulness.

Topics of interest include:

• Personalized medicine approach for cancer treatment. 
• Development of novel therapies and/or novel therapeutic strategies .
• Improvements in the safety and efficacy of stem cell transplantation
• LLS is especially interested in novel immunotherapy approaches and understanding novel immune synapses relevant to blood cancers.
• TRP is interested in focusing on diseases of high unmet need. These can include aggressive diseases or diseases that lack effective therapies

Funding: $250,000 per year ($750,000 total) 
Duration: 3 years

Research Authority due date: 25.9.25
LOI (required) due date: 16.10.25
Full proposal due date: 23.1.26